Gross Margin: A company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage. Calculated as: Gross Income / Total Revenues
Adaptive Biotechnologies Corporation (ADPT) had Gross Margin of 73.60% for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$70.87M |
|
$-20.03M |
|
$18.71M |
|
$52.17M |
|
$90.08M |
|
$-19.21M |
|
$-0.81M |
|
$-20.02M |
|
$-20.02M |
|
$-20.02M |
|
$-20.02M |
|
$-20.02M |
|
$-20.02M |
|
$-19.21M |
|
$-15.51M |
|
155.52M |
|
155.52M |
|
$-0.13 |
|
$-0.13 |
|
| Balance Sheet Financials | |
$291.81M |
|
$30.77M |
|
$214.14M |
|
$505.94M |
|
$87.01M |
|
-- |
|
$194.69M |
|
$281.70M |
|
$224.24M |
|
$103.96M |
|
$224.24M |
|
159.70M |
|
| Cash Flow Statement Financials | |
$-9.54M |
|
$9.14M |
|
$7.50M |
|
$73.18M |
|
$80.29M |
|
$7.11M |
|
$11.93M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.35 |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Gross Margin |
73.60% |
-27.10% |
|
-27.10% |
|
-- |
|
-28.24% |
|
-28.27% |
|
$-10.33M |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
1.67 |
|
1.47 |
|
61.35 |
|
-8.93% |
|
-19.25% |
|
-3.96% |
|
-8.93% |
|
$1.40 |
|
$-0.07 |
|
$-0.06 |
|